DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

Drug Metabolism and Disposition Fast Forward
First published on October 21, 2005; DOI: 10.1124/dmd.105.005785

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.005785v1
dmd.105.005785v2
34/1/176    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cho, T. M
Right arrow Articles by Hodgson, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cho, T. M
Right arrow Articles by Hodgson, E.


Received for publication June 7, 2005.
Revised October 19, 2005.
Accepted for publication October 19, 2005.

In Vitro Metabolism of Naphthalene by Human Liver Microsomal Cytochrome P450 Enzymes

Taehyon M Cho 1, Randy L Rose 1, Ernest Hodgson 1*

1 North Carolina State University

* Address correspondence to: E-mail: ernest_hodgson{at}ncsu.edu

Abstract

The polycyclic aromatic hydrocarbon naphthalene is an environmental pollutant, a component of jet fuel and, since 2000, has been reclassified as a potential human carcinogen. Few studies of the in vitro human metabolism of naphthalene are available and these focus primarily on lung metabolism. The current studies were performed to characterize naphthalene metabolism by human cytochromes P450 (CYP). Naphthalene metabolites from pooled human liver microsomes (pHLM) were trans-1,2- dihydro-1,2-naphthalenediol (dihydrodiol), 1-naphthol, and 2-naphthol. Metabolite production generated Km values of 23, 40, and 116 µM and Vmaxs of 2860, 268, and 22 pmol/mg protein/min., respectively. CYP isoform screening of naphthalene metabolism identified CYP1A2 as the most efficient isoform for producing dihydrodiol and 1-naphthol and CYP3A4 as the most effective for 2- naphthol production. Metabolism of the primary metabolites of naphthalene was also studied to identify secondary metabolites. While 2-naphthol was readily metabolized by pHLM to produce 2,6- and 1,7- dihydroxynaphthalene, dihydrodiol and 1-naphthol were inefficient substrates for pHLM. A series of human CYP isoforms was used to further explore the metabolism of dihydrodiol and 1-naphthol. 1,4-Naphthoquinone and four minor unknown metabolites from 1-naphthol were observed, and 1A2 and 2D6*1 were identified as the most active isoforms for the production of 1,4-naphthoquinone. Dihydrodiol was metabolized by CYP isoforms to three minor unidentified metabolites with CYP3A4 and CYP2A6 having the greatest activity toward this substrate. The metabolism of dihydrodiol by CYP isoforms was lower than that of 1-naphthol. These studies identify primary and secondary metabolites of naphthalene produced by pHLM and CYP isoforms.


Key words: CYP1A, CYP2B, CYP3A, cytochrome P450, cytochrome P450 isoforms, environmental toxicology, human CYP enzymes, liver microsomes, monooxygenases, toxicology


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
G. I. Somers, N. Lindsay, B. M. Lowdon, A. E. Jones, C. Freathy, S. Ho, A. J. M. Woodrooffe, M. K. Bayliss, and G. R. Manchee
A Comparison of the Expression and Metabolizing Activities of Phase I and II Enzymes in Freshly Isolated Human Lung Parenchymal Cells and Cryopreserved Human Hepatocytes
Drug Metab. Dispos., October 1, 2007; 35(10): 1797 - 1805.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
K. A. Usmani, T. M. Cho, R. L. Rose, and E. Hodgson
Inhibition of the Human Liver Microsomal and Human Cytochrome P450 1A2 and 3A4 Metabolism of Estradiol by Deployment-Related and Other Chemicals
Drug Metab. Dispos., September 1, 2006; 34(9): 1606 - 1614.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Z.-L. Wu, C. D. Sohl, T. Shimada, and F. P. Guengerich
Recombinant Enzymes Overexpressed in Bacteria Show Broad Catalytic Specificity of Human Cytochrome P450 2W1 and Limited Activity of Human Cytochrome P450 2S1
Mol. Pharmacol., June 1, 2006; 69(6): 2007 - 2014.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.